Trial Profile
A Phase III, 8-week, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Amlodipine 5mg+Losartan 100mg Versus Losartan 100mg in Patients With Essential Hypertension Not Controlled on Losartan Monotherapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jun 2012
Price :
$35
*
At a glance
- Drugs Amlodipine/losartan (Primary) ; Losartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 21 Jul 2009 New trial record